PET/CT in the management of thyroid cancers

Charles Marcus; Pat W. Whitworth; Devaki S. Surasi; Sara I. Pai; Rathan M. Subramaniam

doi:10.2214/AJR.13.11673

PET/CT in the management of thyroid cancers

Charles Marcus, Pat W. Whitworth, Devaki S. Surasi, Sara I. Pai, Rathan M. Subramaniam

Research output: Contribution to journal › Review article › peer-review

29 Scopus citations

Abstract

OBJECTIVE. Thyroid cancer is the most common endocrine cancer. This review evaluates the established use of ¹⁸F-FDG PET/CT in papillary, follicular, Hürthle cell, anaplastic, and medullary thyroid cancers. The significance of incidental diffuse and focal thyroid FDG uptake is discussed. The evolving value of non-FDG radiotracers, including ¹²⁴I, ¹⁸F-dihydroxyphenylalanine, and ⁶⁸Ga somatostatin analogs, is summarized. CONCLUSION. PET/CT is a valuable imaging test, in the appropriate clinical context, for the management of thyroid cancers.

Original language	English (US)
Pages (from-to)	1316-1329
Number of pages	14
Journal	American Journal of Roentgenology
Volume	202
Issue number	6
DOIs	https://doi.org/10.2214/AJR.13.11673
State	Published - Jun 2014

Keywords

F-DOPA PET/CT
FDG PET/CT
Thyroid cancer

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.2214/AJR.13.11673

Fingerprint Dive into the research topics of 'PET/CT in the management of thyroid cancers'. Together they form a unique fingerprint.

Cite this

@article{6ab23ccea0e64639b8796e773799fc43,

title = "PET/CT in the management of thyroid cancers",

abstract = "OBJECTIVE. Thyroid cancer is the most common endocrine cancer. This review evaluates the established use of 18F-FDG PET/CT in papillary, follicular, H{\"u}rthle cell, anaplastic, and medullary thyroid cancers. The significance of incidental diffuse and focal thyroid FDG uptake is discussed. The evolving value of non-FDG radiotracers, including 124I, 18F-dihydroxyphenylalanine, and 68Ga somatostatin analogs, is summarized. CONCLUSION. PET/CT is a valuable imaging test, in the appropriate clinical context, for the management of thyroid cancers.",

keywords = "F-DOPA PET/CT, FDG PET/CT, Thyroid cancer",

author = "Charles Marcus and Whitworth, {Pat W.} and Surasi, {Devaki S.} and Pai, {Sara I.} and Subramaniam, {Rathan M.}",

year = "2014",

month = jun,

doi = "10.2214/AJR.13.11673",

language = "English (US)",

volume = "202",

pages = "1316--1329",

journal = "American Journal of Roentgenology",

issn = "0361-803X",

publisher = "American Roentgen Ray Society",

number = "6",

}

TY - JOUR

T1 - PET/CT in the management of thyroid cancers

AU - Marcus, Charles

AU - Whitworth, Pat W.

AU - Surasi, Devaki S.

AU - Pai, Sara I.

AU - Subramaniam, Rathan M.

PY - 2014/6

Y1 - 2014/6

N2 - OBJECTIVE. Thyroid cancer is the most common endocrine cancer. This review evaluates the established use of 18F-FDG PET/CT in papillary, follicular, Hürthle cell, anaplastic, and medullary thyroid cancers. The significance of incidental diffuse and focal thyroid FDG uptake is discussed. The evolving value of non-FDG radiotracers, including 124I, 18F-dihydroxyphenylalanine, and 68Ga somatostatin analogs, is summarized. CONCLUSION. PET/CT is a valuable imaging test, in the appropriate clinical context, for the management of thyroid cancers.

AB - OBJECTIVE. Thyroid cancer is the most common endocrine cancer. This review evaluates the established use of 18F-FDG PET/CT in papillary, follicular, Hürthle cell, anaplastic, and medullary thyroid cancers. The significance of incidental diffuse and focal thyroid FDG uptake is discussed. The evolving value of non-FDG radiotracers, including 124I, 18F-dihydroxyphenylalanine, and 68Ga somatostatin analogs, is summarized. CONCLUSION. PET/CT is a valuable imaging test, in the appropriate clinical context, for the management of thyroid cancers.

KW - F-DOPA PET/CT

KW - FDG PET/CT

KW - Thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=84904107810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904107810&partnerID=8YFLogxK

U2 - 10.2214/AJR.13.11673

DO - 10.2214/AJR.13.11673

M3 - Review article

C2 - 24848831

AN - SCOPUS:84904107810

VL - 202

SP - 1316

EP - 1329

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 6

ER -